Fulgent Genetics Inc
NASDAQ:FLGT
Fulgent Genetics Inc
Cash from Investing Activities
Fulgent Genetics Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fulgent Genetics Inc
NASDAQ:FLGT
|
Cash from Investing Activities
$38.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
108%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Cash from Investing Activities
-$771.8m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Investing Activities
-$1.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-21%
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Investing Activities
-$20.9B
|
CAGR 3-Years
-56%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-28%
|
|
Cigna Corp
NYSE:CI
|
Cash from Investing Activities
-$5.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Investing Activities
-$1.5B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-14%
|
See Also
What is Fulgent Genetics Inc's Cash from Investing Activities?
Cash from Investing Activities
38.9m
USD
Based on the financial report for Dec 31, 2023, Fulgent Genetics Inc's Cash from Investing Activities amounts to 38.9m USD.
What is Fulgent Genetics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
108%